![Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis - Digestive and Liver Disease Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis - Digestive and Liver Disease](https://www.dldjournalonline.com/cms/asset/4203302f-15c1-4c6a-b6e3-b0dc2193e743/gr1.jpg)
Vedolizumab as the first line of biologic therapy for ulcerative colitis and Crohn's disease – a systematic review with meta-analysis - Digestive and Liver Disease
![PDF) OP35 Endoscopic and deep remission at 1 year prevents disease progression in early Crohn's disease: long-term data from CALM PDF) OP35 Endoscopic and deep remission at 1 year prevents disease progression in early Crohn's disease: long-term data from CALM](https://i1.rgstatic.net/publication/330645603_OP35_Endoscopic_and_deep_remission_at_1_year_prevents_disease_progression_in_early_Crohn's_disease_long-term_data_from_CALM/links/5e85d3c7a6fdcca789e963e7/largepreview.png)
PDF) OP35 Endoscopic and deep remission at 1 year prevents disease progression in early Crohn's disease: long-term data from CALM
![PDF) Young adults living with inflammatory bowel disease. A thematic synthesis of patient experience. PDF) Young adults living with inflammatory bowel disease. A thematic synthesis of patient experience.](https://i1.rgstatic.net/publication/325952662_Young_adults_living_with_inflammatory_bowel_disease_A_thematic_synthesis_of_patient_experience/links/5b2ea8854585150d23caa253/largepreview.png)
PDF) Young adults living with inflammatory bowel disease. A thematic synthesis of patient experience.
![PDF) Abstract: OP036 Short duration, low intensity pooled faecal microbiota transplantation induces remission in patients with mild-moderately active ulcerative colitis: a randomised controlled trial PDF) Abstract: OP036 Short duration, low intensity pooled faecal microbiota transplantation induces remission in patients with mild-moderately active ulcerative colitis: a randomised controlled trial](https://i1.rgstatic.net/publication/313467511_Abstract_OP036_Short_duration_low_intensity_pooled_faecal_microbiota_transplantation_induces_remission_in_patients_with_mild-moderately_active_ulcerative_colitis_a_randomised_controlled_trial/links/5a78e938aca2722e4df31b42/largepreview.png)
PDF) Abstract: OP036 Short duration, low intensity pooled faecal microbiota transplantation induces remission in patients with mild-moderately active ulcerative colitis: a randomised controlled trial
![ECCO: Improving outcomes for all cancer patients in Europe through multidisciplinarity - Research Outreach ECCO: Improving outcomes for all cancer patients in Europe through multidisciplinarity - Research Outreach](https://researchoutreach.org/wp-content/uploads/2018/06/158_20150925_new-1200x675.jpg)
ECCO: Improving outcomes for all cancer patients in Europe through multidisciplinarity - Research Outreach
![KHUMANIA™ Latest Designer Printed Mobile Back Hard Case Cover for Samsung Galaxy A9 (2018) | Abstract Art, Black, Abstract, Hearts - 6327 KHUMANIA™ Latest Designer Printed Mobile Back Hard Case Cover for Samsung Galaxy A9 (2018) | Abstract Art, Black, Abstract, Hearts - 6327](https://images.meesho.com/images/products/209591446/iecco_512.webp)
KHUMANIA™ Latest Designer Printed Mobile Back Hard Case Cover for Samsung Galaxy A9 (2018) | Abstract Art, Black, Abstract, Hearts - 6327
![PDF) DOP028 Second N-ECCO Consensus Statements on the European nursing roles in caring for patients with Crohn's disease or ulcerative colitis PDF) DOP028 Second N-ECCO Consensus Statements on the European nursing roles in caring for patients with Crohn's disease or ulcerative colitis](https://i1.rgstatic.net/publication/322890443_DOP028_Second_N-ECCO_Consensus_Statements_on_the_European_nursing_roles_in_caring_for_patients_with_Crohn's_disease_or_ulcerative_colitis/links/5c7fc64592851c69505a7e20/largepreview.png)
PDF) DOP028 Second N-ECCO Consensus Statements on the European nursing roles in caring for patients with Crohn's disease or ulcerative colitis
![PDF) European Crohn's and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of Fibrostenosing Crohn's Disease PDF) European Crohn's and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of Fibrostenosing Crohn's Disease](https://i1.rgstatic.net/publication/296469291_European_Crohn's_and_Colitis_Organisation_Topical_Review_on_Prediction_Diagnosis_and_Management_of_Fibrostenosing_Crohn's_Disease/links/5b9d545d45851574f7ce37a6/largepreview.png)
PDF) European Crohn's and Colitis Organisation Topical Review on Prediction, Diagnosis and Management of Fibrostenosing Crohn's Disease
The First European Evidence-based Consensus on Extra-intestinal Manifestations in Inflammatory Bowel Disease
![European Crohn´s and Colitis Organisation - ECCO - Submit your congress abstract and share your research and clinical developments European Crohn´s and Colitis Organisation - ECCO - Submit your congress abstract and share your research and clinical developments](https://ecco-ibd.eu/images/Wladyslawa_Czuber-Dochan_2018.jpg)
European Crohn´s and Colitis Organisation - ECCO - Submit your congress abstract and share your research and clinical developments
![Bertrand Delsuc on Twitter: "AbbVie $ABBV upadacitinib (oral JAK1i) in CD - CELEST study #ECCO18 https://t.co/QkWKXzzbKb https://t.co/uDuNljBrSN" / Twitter Bertrand Delsuc on Twitter: "AbbVie $ABBV upadacitinib (oral JAK1i) in CD - CELEST study #ECCO18 https://t.co/QkWKXzzbKb https://t.co/uDuNljBrSN" / Twitter](https://pbs.twimg.com/media/DVn1I0CVwAAVbci.jpg)